Skip to content
View page with normal contrast
View page with high contrast
Viagra Sildenafil
Kamagra Australia
Biomedical
Kamagra Jelly
climateinstitute
Home
About
Health Professionals
Viagra Sildenafil
Kamagra Australia
Biomedical
Kamagra Jelly
climateinstitute
About the HPV Register
Announcements
Documents
Useful links
Parents & Teens
About the HPV Register
FAQs
Useful links
Research & Data
Research Overview
Coverage Data
Relevant Research Publications
Useful links
HPV Vaccination Coverage by Dose 2012
HPV vaccination coverage by dose number (Australia) for females by age group in mid 2012
Age
(in years at mid 2012)
12 - 13
14 - 15
16 - 17
18 - 19
20 -26
Population
(in years at mid 2012)
272,500
273,925
281,950
290,661
1,129,042
Total no. of doses
notified
682,639
645,462
659,523
659,886
1,817,268
Coverage
Rate (as at
30 June 2018)
DOSE 1
88%
84%
83%
81%
62%
DOSE 2
84%
80%
79%
77%
55%
DOSE 3
78%
72%
72%
69%
44%
HPV vaccination coverage by dose number (Australia) for females by age group in mid 2012
September 2018| 222 KB
NOTES
Data extracted from the National HPV Vaccination Program Register (HPV Register) as at 04 JULY 2018 and includes females vaccinated between APR 2007 and JUN 2018.
Includes doses that comply with the recommended vaccine dosage and administration as per the Australian Immunisation Handbook (up to 3 doses administered at prescribed intervals).
Estimated Resident Population 2012 (as at 30/06/2012) is from the Australian Bureau of Statistics - Cat 3101.0 Australian Demographic Statistics, Tables 51 to 58: Estimated Resident Population By Single year of Age by State and Territory, FINAL based on 2016 census data published JUN 2018.
Age is age as at date of ERP estimate (30th June 2012).
Coverage is calculated as doses administered and reported to the HPV Register/estimated resident population expressed as a percentage.
Excludes consumers who do not wish their details to be recorded on the HPV Register.
Dose number is calculated according to the number of doses held by the register for each person. Incoming records are matched to existing records for that person and date of administration is used to determine the dose number.
The National HPV Vaccination Program initially provided quadrivalent HPV vaccine for all females aged 12-26 years as at mid 2007 ( school program commenced April 2007 and GP/community program in July 2007) until end December 2009. From 2009 the Program offered HPV vaccination routinely to females in the first year of high school (usually at 12-13 years). From 2013, males were also offered HPV vaccination routinely in the first year of high school (age 12-13 years), with a catch-up program available for males aged 14-15 years in 2013 and 2014.
HPV Vaccination doses administered through general practice and in other community settings may be incompletely notified to the HPV Register. The extent of under notification differs by jurisdiction, with the Northern Territory and Queensland expected to have the most complete notification, due to notification of doses via State based immunisation registers.
Research Overview
Coverage Data
Relevant Research Publications
Useful links